Molecular genetic testing and the future of clinical genomics.

Loading...
Thumbnail Image

Date

2013-06

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

192
views
241
downloads

Citation Stats

Abstract

Genomic technologies are reaching the point of being able to detect genetic variation in patients at high accuracy and reduced cost, offering the promise of fundamentally altering medicine. Still, although scientists and policy advisers grapple with how to interpret and how to handle the onslaught and ambiguity of genome-wide data, established and well-validated molecular technologies continue to have an important role, especially in regions of the world that have more limited access to next-generation sequencing capabilities. Here we review the range of methods currently available in a clinical setting as well as emerging approaches in clinical molecular diagnostics. In parallel, we outline implementation challenges that will be necessary to address to ensure the future of genetic medicine.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1038/nrg3493

Publication Info

Katsanis, Sara Huston, and Nicholas Katsanis (2013). Molecular genetic testing and the future of clinical genomics. Nature reviews. Genetics, 14(6). pp. 415–426. 10.1038/nrg3493 Retrieved from https://hdl.handle.net/10161/17569.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.